These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1758848)

  • 21. Effects of stroma-free hemoglobin solutions on pulmonary vascular resistance and mediator release in the isolated perfused rabbit lung.
    Koch T; Duncker HP; Heller A; Schaible R; van Ackern K; Neuhof H
    Shock; 1994 Feb; 1(2):146-52. PubMed ID: 7538430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelium-derived relaxing factor activity in rat lung during hypoxic pulmonary vascular remodeling.
    Zhao L; Crawley DE; Hughes JM; Evans TW; Winter RJ
    J Appl Physiol (1985); 1993 Mar; 74(3):1061-5. PubMed ID: 8482643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF potentiates PAF-induced pulmonary vasoconstriction in the rat: role of neutrophils and thromboxane A2.
    Chang SW
    J Appl Physiol (1985); 1994 Dec; 77(6):2817-26. PubMed ID: 7896627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone potentiates hypoxic vasoconstriction in salt solution-perfused rat lungs.
    Herget J; McMurtry IF
    Am J Physiol; 1987 Sep; 253(3 Pt 2):H574-81. PubMed ID: 3631295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney.
    Perico N; Lapinski R; Konopka K; Aiello S; Noris M; Remuzzi G
    J Am Soc Nephrol; 1997 Sep; 8(9):1391-8. PubMed ID: 9294830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intact lung cytochrome P-450 is not required for hypoxic pulmonary vasoconstriction.
    Chang SW; Dutton D; Wang HL; He LS; Stearns R; Hui A; Giacomini KM; Ortiz de Montellano P; Voelkel NF
    Am J Physiol; 1992 Oct; 263(4 Pt 1):L446-53. PubMed ID: 1415722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport.
    Horvath CJ; Kaplan JE; Malik AB
    Am Rev Respir Dis; 1991 Dec; 144(6):1337-41. PubMed ID: 1741548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of hepatic glycogenolysis and vasoconstriction during antigen-induced anaphylaxis.
    Hines KL; Fisher RA
    Am J Physiol; 1992 May; 262(5 Pt 1):G868-77. PubMed ID: 1375439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine.
    Siebeck M; Weipert J; Keser C; Kohl J; Spannagl M; Machleidt W; Schweiberer L
    J Trauma; 1991 Jul; 31(7):942-9; discussion 949-50. PubMed ID: 1906548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-activating factor causes pulmonary vasodilation in the rat.
    McMurtry IF; Morris KG
    Am Rev Respir Dis; 1986 Oct; 134(4):757-62. PubMed ID: 3094417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin is not required for hypoxic constriction in salt solution-perfused rat lungs.
    McMurtry IF
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Feb; 56(2):375-80. PubMed ID: 6561197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dithionite increases radical formation and decreases vasoconstriction in the lung. Evidence that dithionite does not mimic alveolar hypoxia.
    Archer SL; Hampl V; Nelson DP; Sidney E; Peterson DA; Weir EK
    Circ Res; 1995 Jul; 77(1):174-81. PubMed ID: 7788875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of BQ123 on vasoconstriction as a result of either hypoxia or endothelin-1 in perfused rat lungs.
    Takeoka M; Ishizaki T; Sakai A; Chang SW; Shigemori K; Higashi T; Ueda G
    Acta Physiol Scand; 1995 Sep; 155(1):53-60. PubMed ID: 8553877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Almitrine mimics hypoxic vasoconstriction in isolated rat lungs.
    Gottschall EB; Fernyak S; Wuertemberger G; Voelkel NF
    Am J Physiol; 1992 Aug; 263(2 Pt 2):H383-91. PubMed ID: 1510135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of oxidative ATP production cause transient vasoconstriction and block subsequent pressor responses in rat lungs.
    Rounds S; McMurtry IF
    Circ Res; 1981 Mar; 48(3):393-400. PubMed ID: 7460212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
    Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ
    J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet activating factor and histamine effects in synovial blood flow evaluated by laser-Doppler flowmetry.
    Rocha FA; Jancar S; Fraga CA; Timo-Iaria C; De Brum-Fernandes AJ
    J Rheumatol; 1993 Aug; 20(8):1374-7. PubMed ID: 8230022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary vascular reactivity in Fischer rats.
    He LS; Chang SW; Voelkel NF
    J Appl Physiol (1985); 1991 Apr; 70(4):1861-6. PubMed ID: 2055865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.